Crossmark

Management of immune checkpoint therapy for patients with cancer in the face of COVID-19

Crossref DOI link: https://doi.org/10.1136/jitc-2020-001593

Published Online: 2020-12-10

Published Print: 2020-12

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Shen, Chen

Li, Qianru

Wei, Yongchang

Li, Yuting

Li, Jun

Tao, Juan
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct04268537 at ClinicalTrials.gov

Documents that mention this clinical trial

Management of immune checkpoint therapy for patients with cancer in the face of COVID-19
https://doi.org/10.1136/jitc-2020-001593

Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors
https://doi.org/10.1136/jitc-2021-002835
License Information

License valid from 2020-12-10